Kura Oncology
Kura Oncology is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Kura Oncology products.
Drugs from Kura Oncology supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Komzifti | ziftomenib | Oncology (Leukemia) | R/R NPM1-mutant acute myeloid leukemia (AML) |
How NPP access to Kura Oncology products works
Reserve Meds sources Kura Oncology products from a US-licensed pharmaceutical wholesale partner, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Kura Oncology
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Kura Oncology.